Annual Rebalancing
EUR
Moderate Risk
1.5yr backtest
Analyse this portfolio

Performance Summary

Total Return+29.09%
Annualized Return+18.02%
Volatility+11.14%
Sharpe Ratio1.44
Max Drawdown+9.43%

Holdings

Asset Allocation

Asset Class

Equity 72.5%Precious Metals 15.0%Bonds 12.5%
Holdings Details
Diversified ETF portfolio blending global stocks, bonds, and gold for robust asset allocation and long-term growth potential.
AssetTypeAllocationTER
VWCE.XETRA
Vanguard FTSE All-World UCITS ETF (USD) Accumulating • IE00BK5BQT80
ETF
40.0%0.19%
GLDA.F
Amundi Physical Gold ETC C EUR • FR0013416716
ETC
15.0%0.12%
DBMFE.PA
iMGP DBi Managed Futures Fund R EUR ETF UCITS ETF • LU2951555403
ETF
12.5%0.75%
LYXF.XETRA
Amundi Euro Government Bond 15+Y UCITS ETF Acc • LU1287023268
ETF
12.5%0.15%
AVWS.XETRA
Avantis Global Small Cap Value UCITS ETF USD Acc • IE0003R87OG3
ETF
10.0%0.39%
IS3R.XETRA
iShares Edge MSCI World Momentum Factor UCITS ETF (Acc) • IE00BP3QZ825
ETF
10.0%0.25%
Total100.0%0.27%

Performance

Portfolio Value Over Time
Starting with €10,000 investment → now worth €12,909.4
Histogram of Monthly Returns
The portfolio had a positive return during 15 of the 19 months (79%)
Monthly Returns Heatmap
Best month: +5.0% • Worst month: -5.2% • Best year: 2026 (+13.9%) • Worst year: 2025 (+13.4%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+3.5%+3.7%-5.2%+5.0%+3.7%+0.6%-1.9%+1.9%+1.2%+0.8%--+13.9%
2025----3.2%+4.0%-0.5%+3.2%+0.1%+3.9%+4.3%+0.5%+0.8%+13.4%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +9.43% • The longest drawdown period lasted for 2 months and was between March 2026 and May 2026. It reached a trough of -6.5%.

Detailed Metrics

Returns
Total Return
+29.09%
Annualized Return
+18.02%
Avg Monthly Return
+1.39%
Risk
Volatility (Annual)
+11.14%
Max Drawdown
+9.43%
Positive Months
79%
Average Drawdown
-1.4%
Risk-Adjusted
Sharpe Ratio
1.44
Risk-free rate: 2.0%
Sortino Ratio
1.40
Downside risk adjusted
Return/Volatility
1.62
Calmar Ratio
1.91
Return/Max Drawdown
Ulcer Index
1.92
Drawdown depth & duration
Martin Ratio
0.08
Return/Ulcer Index
Backtest Configuration
Initial Investment
€10,000
Final Value
€12,909.4
Backtest Period
2025-04-01 to 2026-10-16
1.5 years
Rebalancing
annual
Base Currency
EUR